These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 32613106)

  • 21. In vitro evaluation of Malassezia pachydermatis susceptibility to azole compounds using E-test and CLSI microdilution methods.
    Cafarchia C; Figueredo LA; Iatta R; Colao V; Montagna MT; Otranto D
    Med Mycol; 2012 Nov; 50(8):795-801. PubMed ID: 22471886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Characterization of species of the gender Malassezia in patients with seborrheic dermatitis and subjects without skin lesions].
    Rendic E; Díaz C; Fich F
    Rev Med Chil; 2003 Nov; 131(11):1295-300. PubMed ID: 14743691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Malassezia species isolated from some Malassezia associated skin diseases.
    Hamdino M; Saudy AA; El-Shahed LH; Taha M
    J Mycol Med; 2022 Nov; 32(4):101301. PubMed ID: 35700659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Malassezia genus in skin and systemic diseases.
    Gaitanis G; Magiatis P; Hantschke M; Bassukas ID; Velegraki A
    Clin Microbiol Rev; 2012 Jan; 25(1):106-41. PubMed ID: 22232373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro sensitivity of Malassezia furfur isolates from HIV-positive and negative patients to antifungal agents.
    Ehemann K; Contreras A; Celis-Ramírez AM
    Biomedica; 2023 Aug; 43(Sp. 1):120-131. PubMed ID: 37721914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An azole-resistant isolate of Malassezia pachydermatis.
    Nijima M; Kano R; Nagata M; Hasegawa A; Kamata H
    Vet Microbiol; 2011 Apr; 149(1-2):288-90. PubMed ID: 21074337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology and susceptibility profile to classic antifungals and over-the-counter products of Malassezia clinical isolates from a Portuguese University Hospital: a prospective study.
    Pedrosa AF; Lisboa C; Faria-Ramos I; Silva R; Ricardo E; Teixeira-Santos R; Miranda I; Rodrigues AG
    J Med Microbiol; 2019 May; 68(5):778-784. PubMed ID: 30907722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution of Malassezia Species from Scales of Patient with Pityriasis Versicolor by Culture in Vietnam.
    Cam VT; Van TN; Hau KT; Huu DL; Minh PPT; Huu SN; Minh TN; Gandolfi M; Satolli F; Feliciani C; Tirant M; Vojvodic A; Lotti T
    Open Access Maced J Med Sci; 2019 Jan; 7(2):184-186. PubMed ID: 30745953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antifungal activities of azole agents against the Malassezia species.
    Miranda KC; de Araujo CR; Costa CR; Passos XS; de Fátima Lisboa Fernandes O; do Rosário Rodrigues Silva M
    Int J Antimicrob Agents; 2007 Mar; 29(3):281-4. PubMed ID: 17223320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cutaneous Malassezia infections and Malassezia associated dermatoses: An update].
    Nenoff P; Krüger C; Mayser P
    Hautarzt; 2015 Jun; 66(6):465-84; quiz 485-6. PubMed ID: 25968082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution of Malassezia species in pityriasis versicolor and seborrhoeic dermatitis in Greece. Typing of the major pityriasis versicolor isolate M. globosa.
    Gaitanis G; Velegraki A; Alexopoulos EC; Chasapi V; Tsigonia A; Katsambas A
    Br J Dermatol; 2006 May; 154(5):854-9. PubMed ID: 16634886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of fatty acid RPMI 1640 media for testing susceptibilities of eight Malassezia species to the new triazole posaconazole and to six established antifungal agents by a modified NCCLS M27-A2 microdilution method and Etest.
    Velegraki A; Alexopoulos EC; Kritikou S; Gaitanis G
    J Clin Microbiol; 2004 Aug; 42(8):3589-93. PubMed ID: 15297502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Real-Time PCR Identification of Six Malassezia Species.
    Ilahi A; Hadrich I; Neji S; Trabelsi H; Makni F; Ayadi A
    Curr Microbiol; 2017 Jun; 74(6):671-677. PubMed ID: 28332161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multi-azole-resistant strain of Malassezia pachydermatis isolated from a canine Malassezia dermatitis.
    Kano R; Yokoi S; Kariya N; Oshimo K; Kamata H
    Med Mycol; 2019 Apr; 57(3):346-350. PubMed ID: 29800467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular identification of Malassezia species isolated from dermatitis affections.
    Affes M; Ben Salah S; Makni F; Sellami H; Ayadi A
    Mycoses; 2009 May; 52(3):251-6. PubMed ID: 18643889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell-mediated immune responses to Malassezia furfur serovars A, B and C in patients with pityriasis versicolor, seborrheic dermatitis and controls.
    Ashbee HR; Ingham E; Holland KT; Cunliffe WJ
    Exp Dermatol; 1994 Jun; 3(3):106-12. PubMed ID: 7952921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro combination of antifungal agents against Malassezia pachydermatis.
    Schlemmer KB; de Jesus FPK; Loreto ES; Farias JB; Alves SH; Ferreiro L; Santurio JM
    Med Mycol; 2019 Apr; 57(3):324-327. PubMed ID: 29924372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro susceptibility testing of Malassezia furfur against rilopirox.
    Nenoff P; Haustein UF
    Skin Pharmacol; 1997; 10(5-6):275-80. PubMed ID: 9449166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro susceptibility of Malassezia pachydermatis isolates from canine skin with atopic dermatitis to ketoconazole and itraconazole in East Asia.
    Watanabe S; Koike A; Kano R; Nagata M; Chen C; Hwang CY; Hasegawa A; Kamata H
    J Vet Med Sci; 2014 Apr; 76(4):579-81. PubMed ID: 24334863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of
    Gholami M; Mokhtari F; Mohammadi R
    Curr Med Mycol; 2020 Sep; 6(3):21-26. PubMed ID: 33834139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.